Company intelligence / Profile preview

Proteos Biotech

Madrid, Madrid Community, Spainproteosbiotech.com ↗

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

Proteos Biotech develops and manufactures recombinant enzymes used in class III injectable medical devices and cosmeceuticals to treat a range of skin conditions. Their products are internationally certified (ISO13485/22716) with demonstrated safety/purity/stability. The company has published scientific articles supporting efficacy but does not appear to have traditional pharmaceutical clinical trial results or approved drugs—focus remains on medical device/cosmetic markets rather than prescription therapeutics.

Therapeutic areas: OtherDermatologyCardiovascular
Modalities: Recombinant proteinRecombinant enzymeProteinPeptidesSmall molecule
Industry: Therapeutic Medical Devices

Partnerships

MOEHS GroupTres Mares Capitalcontract manufacturing clients worldwide

Beyond the preview

Go deeper on Proteos Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proteos Biotech.

Explore the full profile